The ThromboAblation in Acute Myo-cardial Infarction trial has begun enrolling participants. The 200-patient randomized trial, to be performed by Spectranetics Corp. of Colorado Springs, Colo., will test the usefulness of excimer lasers in treating people with a large thrombus burden presenting with ST wave elevation myocardial infarction.